This content is machine translated Diabetes Cases Type 2 diabetes mellitus and advanced renal failure A 73-year-old female patient who has had type 2 diabetes mellitus for 10 years is unhappy with her weight and needs improved glycemic control. However, macronutrient malnutrition combined with advanced…
View Post 1 min This content is machine translated IBD matters State of the art in IBD treatment The classic symptoms of inflammatory bowel disease (IBD) range from mild abdominal pain to colicky symptoms and persistent diarrhea. Phases of low disease activity may be followed by severe episodes.…
View Post 6 min This content is machine translated Diabetes treatment Insulin therapy in type 2 diabetics: an update. The most modern representatives of basal insulins are ultra-long acting and associated with low hypoglycemia rates. Mixed insulin or combination preparations of GLP-1-RA and a long-acting insulin are good alternatives…
View Post 4 min This content is machine translated Diabetes treatment Additive glucose-lowering therapy for type 1 diabetics – weighing benefits and risks Overweight type 1 diabetics in whom insulin therapy alone is not sufficient for glycemic control may receive additional oral treatment with the SGLT2 inhibitor dapagliflozin or the dual SGLT1/SGLT2 inhibitor…
View Post 1 min This content is machine translated Online training Swiss Oncology in Motion Acute Myeloid Leukemia Module After many years without noticeable therapeutic progress, a number of new treatment options for acute myeloid leukemia have recently become available that could improve the situation for those affected. Prof.… CME-Test
View Post 11 min This content is machine translated Role of incretin-based therapy GLP-1-RA and DPP-4 inhibitors in the management of type 2 diabetes. Insulin secretion by pancreatic beta cells is primarily influenced by glucose levels in the portal vein. In addition, secretion is also modulated by the so-called incretins. After food intake, they…
View Post 3 min This content is machine translated GLP-1 receptor agonists in type 2 diabetes Nephroprotection with semaglutide and liraglutide – direct or indirect effects? In a post-hoc analysis of large randomized placebo-controlled trials, HbA1c and body weight and blood pressure were examined as mediator variables regarding the renal protective effects of the GLP-1 receptor…
View Post 3 min This content is machine translated Diabetic ketoacidosis Study: ketoacidosis in infancy affects brain development Diabetic ketoacidosis (DKA) can have consequences for a child’s brain, an American research group shows in the journal Diabetes Care. The German Diabetes Society (DDG) points out the need to…
View Post 6 min This content is machine translated PUBLIC REPORT Ginkgo biloba – a miracle cure for cognitive brain disorders and dementia? Although in relative terms dementia is slightly decreasing in the population, in absolute terms we are encountering more and more people with dementia due to the increase in life expectancy…
View Post 1 min This content is machine translated T2DM X-CHANGE 2020 The Kidney as a Window to the Heart – Holistic Treatment of Type 2 Diabetes It has long been known that type 2 diabetes not only increases the risk of cardiovascular disease, but is also one of the main causes of kidney disease. What consequences…
View Post 5 min This content is machine translated Corona pandemic Current data on COVID-19 and diabetes In particular, older diabetics with a high BMI have an increased risk of a severe course and mortality rates are also higher compared to the general population. The interactions involved…
